Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction

Hypertension

Volumn 30, Issue 5, 1997, Pages 1020-1024

  Haider, Agha W ^a,c   Chen, Leway ^a   Larson, Martin G ^a,c   Evans, Jane C ^a,c   Chen, Ming Hui ^a,d   Levy, Daniel ^a,b,c,d,e  

^a Blood Inst's F   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e FRAMINGHAM HEART STUDY   (United States)

Author keywords

Epidemiology; Framingham Heart Study; Myocardial infarction; Prognosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; FEMALE; GLUCOSE INTOLERANCE; HEART REINFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0030720858     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1020     Document Type: Article

References (35)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571-1576.
2. Working group report on primary prevention of hypertension. National High Blood Pressure Education Program. Bethesda, Md: National Institute of Health; 1993. National Heart, Lung and Blood Institute document. 1993:2669 Bethesda: National Institute of Health.
3. Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to serum cholesterol concentration, cigarette smoking and diastolic blood pressure among black and white males followed up for five years. Am Heart J 1984;108: 759-769.
4. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am J Cordiol. 1971;27:335-346.
5. Kannel WB, Sorlie P, Castelli WP, McGee D. Blood pressure and survival after myocardial infarction: the Framingham Study. Am J Cardiol. 1980;45:326-330.
6. Rabkin SW, Mathewson FA, Tate RB. Prognosis after acute myocardial infarction: relation to blood pressure values before infarction in a prospective cardiovascular study. Am J Cardiol. 1977;40:604-610.
7. Herlitz J, Karlson BW, Richter A, Wiklund O, Jablonskiene D, Hjalmarson A. Prognosis in hypertensives with acute myocardial infarction. J Hypertens. 1992;10:1265-1271.
8. Volpi A, DeVita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tagnoni G, for the Ad Hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Base. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation. 1993;88:416-429.
9. Wong ND, Cupples LA, Ostfeld AM, Levy D, Kannel WB. Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham study. Am J Epidemiol. 1989;130: 469-480.
10. Berger CJ, Murabito JM, Evans JC, Anderson KM, Levy D. Prognosis after first myocardial infarction: comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham heart study. JAMA. 1992;268:1545-1551.
11. Weinblatt E, Shapiro S, Frank CW, Sager RV. Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health. 1968;58:1329-1347.
12. Flack JM, Neaton JD, Grimm RJ, Shih J, Cutler J, Ensrud K, MacMahon S. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation. 1995;92:2437-2445.
13. Herlitz J, Bang A, Karlson BW. Five-year prognosis after acute myocardial infarction in relation to a history of hypertension. Am J Hypertens. 1996;9:70-76.
14. Tofler GH, Muller JE, Stone PH, Willich SN, Davis VG, Poole WK, Braunwald E. Factors leading to shorter survival after acute myocardial infarction in patients age 65-75 years compared with younger patients. Am J Cardiol. 1988;62:860-867.
15. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992;152:56-64.
16. Karlson BW, Herlitz J, Hjalmarson A. Does a history of hypertension influence the prognosis among diabetics with acute chest pain? J Clin Epidemiol. 1994;47:773-777.
17. Bueno H, Vidan MT, Almazan A, Lopez-Sendon JL, Delcan JL. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction. Circulation. 1995;92:1133-1140.
18. The Coronary Drug Project research group. Blood pressure in survivors of myocardial infarction. J Am Coll Cardiol. 1984;4: 1135-1147.
19. Khaw KT, Barret-connor E. Prognostic factors for mortality in a population based study of men and women with a history of heart disease. J Cardpulm Rehabil. 1986;6:480.
20. Schlant RC, Forman S, Stamler J, Canner PL. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men: the 5-year findings of the coronary drug project. Circulation. 1982;66:401-414.
21. Sanz G, Castaner A, Betriu A, Magrina J, Roig E, Coll S, Pare JC, Navarro-Lopez F. Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med. 1982;306:1065-1070.
22. Astrup J, Bisgaard-Frantzen HO, Nielsen SL. Blood pressure lowering effects of acute myocardial infarction. Lancet. 1976;2:903.
23. Gibson T. Blood pressure levels in acute myocardial infarction. Am Heart J. 1978;96:475-480.
24. Dawber TR, Meadors GF, Moore FEJ. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1997;41:279-286.
25. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
26. Kannel WB, Wolf P, Garrison RJ. The Framingham Study: an epidemiological investigation of cardiovascular disease Section 34 - some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements Framingham Heart Study, 30 year follow-up. Bethesda, Md: National Institute of Health; 1988 PB87-177499:9-13.
27. Joint National Committee on Detection Evaluation and treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
28. Margolis JR, Kannel WB, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction-silent and symptomatic - eighteen year follow-up: the Framingham Study. Am J Cardiol. 1973;32:1-7.
29. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med. 1969;71:89-105.
30. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study. Ann Intern Med. 1970;72:813-822.
31. SAS Technical Report. SAS/STAT Software: Changes and Enhancements, Release 6.07, Chapter 19 (The PHREG Procedure). P-229, 433-480. Cary, NC: SAS Institute. Inc; 1990.
32. Cox D, Oakes D. Analysis of survival data. Chapman & Hall, 1984.
33. Reaven GM. Insulin resistance and compensatory hyperinsulin-emia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J. 1991;121:1283-1288.
34. Dominiczak AF. Nitric oxide and its putative role in hypertension. Hypertension. 1995;25:1202-1211.
35. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.